SYSTEMIC ADMINISTRATION OF DOXORUBICIN-CONTAINING LIPOSOMES IN CANCER-PATIENTS - A PHASE-1 STUDY

被引：95

作者：

GABIZON, A ^{[1
]}

PERETZ, T ^{[1
]}

SULKES, A ^{[1
]}

AMSELEM, S ^{[1
]}

BENYOSEF, R ^{[1
]}

BENBARUCH, N ^{[1
]}

CATANE, R ^{[1
]}

BIRAN, S ^{[1
]}

BARENHOLZ, Y ^{[1
]}

机构：

[1] HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT MEMBRANE BIOCHEM, IL-91010 JERUSALEM, ISRAEL

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 12期

关键词：

D O I：

10.1016/0277-5379(89)90350-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1795 / 1803

页数：9

共 47 条

[1]

BARTLETT GR, 1959, J BIOL CHEM, V234, P466

[2]

BEIJNEN J H, 1985, Journal of Parenteral Science and Technology, V39, P220

[3]

ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].

BLUM, RH ;

CARTER, SK .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259

[4]

SEPARATION OF LIPOSOME-ASSOCIATED DOXORUBICIN FROM NON-LIPOSOME-ASSOCIATED DOXORUBICIN IN HUMAN-PLASMA - IMPLICATIONS FOR PHARMACOKINETIC STUDIES [J].

DRUCKMANN, S ;

GABIZON, A ;

BARENHOLZ, Y .

BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 980 (03) :381-384

[5]

EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO

[6]

2-4

[7]

USE OF ANIONIC LIPOSOMES FOR THE REDUCTION OF CHRONIC DOXORUBICIN-INDUCED CARDIOTOXICITY [J].

FORSSEN, EA ;

TOKES, ZA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (03) :1873-1877

[8]

FORSSEN EA, 1983, CANCER RES, V43, P546

[9]

GABIZON A, 1989, P391

[10]

SUPERIOR THERAPEUTIC ACTIVITY OF LIPOSOME-ASSOCIATED ADRIAMYCIN IN A MURINE METASTATIC TUMOR-MODEL [J].

GABIZON, A ;

GOREN, D ;

FUKS, Z ;

MESHORER, A ;

BARENHOLZ, Y .

BRITISH JOURNAL OF CANCER, 1985, 51 (05) :681-689

← 1 2 3 4 5 →